143 related articles for article (PubMed ID: 8786451)
1. Spinal amino acid release and precipitated withdrawal in rats chronically infused with spinal morphine.
Jhamandas KH; Marsala M; Ibuki T; Yaksh TL
J Neurosci; 1996 Apr; 16(8):2758-66. PubMed ID: 8786451
[TBL] [Abstract][Full Text] [Related]
2. Spinal amino acid release and repeated withdrawal in spinal morphine tolerant rats.
Ibuki T; Marsala M; Masuyama T; Yaksh TL
Br J Pharmacol; 2003 Feb; 138(4):689-97. PubMed ID: 12598423
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive potentiation and attenuation of tolerance by intrathecal electric stimulation in rats.
Lin CR; Yang LC; You HL; Lee CT; Tai MH; Tan PH; Lin MW; Cheng JT
Anesth Analg; 2003 Jun; 96(6):1711-1716. PubMed ID: 12761002
[TBL] [Abstract][Full Text] [Related]
4. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids.
Tokuyama S; Zhu H; Oh S; Ho IK; Yamamoto T
Neurochem Int; 2001 Aug; 39(2):103-9. PubMed ID: 11408088
[TBL] [Abstract][Full Text] [Related]
5. Resting and evoked spinal substance P release during chronic intrathecal morphine infusion: parallels with tolerance and dependence.
Gu G; Kondo I; Hua XY; Yaksh TL
J Pharmacol Exp Ther; 2005 Sep; 314(3):1362-9. PubMed ID: 15908510
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats.
McCarthy RJ; Kroin JS; Tuman KJ; Penn RD; Ivankovich AD
Anesth Analg; 1998 Apr; 86(4):830-6. PubMed ID: 9539610
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome.
Tokuyama S; Wakabayashi H; Ho IK
Eur J Pharmacol; 1996 Jan; 295(2-3):123-9. PubMed ID: 8720575
[TBL] [Abstract][Full Text] [Related]
8. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
Bell JA; Beglan CL
Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
[TBL] [Abstract][Full Text] [Related]
9. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors.
Sakurada T; Watanabe C; Okuda K; Sugiyama A; Moriyama T; Sakurada C; Tan-No K; Sakurada S
Brain Res Mol Brain Res; 2002 Jan; 98(1-2):111-8. PubMed ID: 11834301
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat.
Taylor JR; Punch LJ; Elsworth JD
Psychopharmacology (Berl); 1998 Jul; 138(2):133-42. PubMed ID: 9718282
[TBL] [Abstract][Full Text] [Related]
12. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats.
Tokuyama S; Zhu H; Wakabayashi H; Feng YZ; Ho IK
J Biomed Sci; 1998; 5(1):45-53. PubMed ID: 9570513
[TBL] [Abstract][Full Text] [Related]
13. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence.
Makimura M; Sugimoto H; Shinomiya K; Kabasawa Y; Fukuda H
J Toxicol Sci; 1996 May; 21(2):135-41. PubMed ID: 8780997
[TBL] [Abstract][Full Text] [Related]
15. The role of spinal nitric oxide and glutamate in nociceptive behaviour evoked by high-dose intrathecal morphine in rats.
Watanabe C; Sakurada T; Okuda K; Sakurada C; Ando R; Sakurada S
Pain; 2003 Dec; 106(3):269-283. PubMed ID: 14659510
[TBL] [Abstract][Full Text] [Related]
16. [Muscarinic receptors modulate the mRNA expression of NMDA receptors in brainstem and the release of glutamate in periaqueductal grey during morphine withdrawal in rats].
Liu HF; Zhou WH; Xie XH; Cao JL; Gu J; Yang GD
Sheng Li Xue Bao; 2004 Feb; 56(1):95-100. PubMed ID: 14985837
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of ultra-low dose naloxone attenuates morphine tolerance in rats via attenuation of NMDA receptor neurotransmission and suppression of neuroinflammation in the spinal cords.
Lin SL; Tsai RY; Shen CH; Lin FH; Wang JJ; Hsin ST; Wong CS
Pharmacol Biochem Behav; 2010 Aug; 96(2):236-45. PubMed ID: 20478329
[TBL] [Abstract][Full Text] [Related]
18. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
Buccafusco JJ; Terry AV; Shuster L
Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880
[TBL] [Abstract][Full Text] [Related]
19. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat.
Zhang T; Feng Y; Rockhold RW; Ho IK
Life Sci; 1994; 55(2):PL25-31. PubMed ID: 7912397
[TBL] [Abstract][Full Text] [Related]
20. Excitatory amino acid release in the locus coeruleus during naloxone-precipitated morphine withdrawal in adjuvant arthritic rats.
Hoshi K; Yamamoto A; Ishizuki S; Fujihira E; Ichihara K
Inflamm Res; 2000 Jan; 49(1):36-41. PubMed ID: 10778919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
